Übersichtsarbeit
Reading and Interpreting Quality-of-Life Results in Cancer Trials
NEJM Evidence · 27.05.2025 · 4 (6)
DOI: 10.1056/evidra2400340 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift NEJM Evidence, erschienen am 27.05.2025. Verfasst von Massimo Di Maio. Beteiligte Einrichtung: Department of Oncology, University of Turin. Hauptthemen laut MEDLINE: Quality of Life, Neoplasms, Clinical Trials as Topic, Patient Reported Outcome Measures. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Quality of LifeNeoplasmsClinical Trials as TopicPatient Reported Outcome MeasuresHumans
Autor:innen und Institutionen
- Department of Oncology, University of Turin.
ORCID-Profile: Massimo Di Maio
Zitieren
APA
Di Maio, M. (2025). Reading and Interpreting Quality-of-Life Results in Cancer Trials. NEJM Evidence, 4(6). https://doi.org/10.1056/evidra2400340
Vancouver
Di Maio M. Reading and Interpreting Quality-of-Life Results in Cancer Trials. NEJM Evidence. 2025;4(6). doi:10.1056/evidra2400340
BibTeX
@article{DiMaio2025,
author = {Di Maio, Massimo},
title = {Reading and Interpreting Quality-of-Life Results in Cancer Trials},
journal = {NEJM Evidence},
year = {2025},
volume = {4},
number = {6},
doi = {10.1056/evidra2400340}
}
EUVIMED